Long-term results of irritable bowel syndrome treatment

Long-term results of irritable bowel syndrome treatment

Aim of investigation. To estimate duration of remission of irritable bowel syndrome after treatment by multistrain probiotic drug, motility regulator or antispasmodic medication. Material and methods. Original study included overall 87 patients with irritable bowel syndrome (IBS) or IBS in combinati...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. I. Ulyanin, Yu. M. Poluektov, Ye. A. Poluektova, Ch. S. Pavlov, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	синдром раздраженного кишечника пробиотики спазмолитики
Online Access:	https://www.gastro-j.ru/jour/article/view/214
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Potential of nutraceutical products for irritable bowel syndrome remission maintenance
by: A. I. Ulyanin, et al.
Published: (2018-08-01)

Comparative of relation of American, German, French and Russian guidelines on irritable bowel syndrome management
by: Arkady A. Sheptulin, et al.
Published: (2016-08-01)

Irritable bowel syndrome concept from the gut microbiom point of view
by: Anna F. Sheptulina, et al.
Published: (2018-08-01)

Dysphoric spectrum of emotional disorders at irritable bowel syndrome
by: M. A. Morozova, et al.
Published: (2018-08-01)

Review of Rome-IV criteria for the irritable bowel syndrome: are there any basic changes?
by: A. A. Sheptulin, et al.
Published: (2018-08-01)

Diagnosis and treatment of the irritable bowel syndrome: clinical guidelines of the Russian gastroenterological association and Russian association of coloproctology
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Diet with decreased content of fermentable oligo-, diand monosaccharides and polyols (low FODMAP-diet) in treatment of irritable bowel syndrome
by: I. L. Khalif, et al.
Published: (2018-08-01)

Patterns of colonic dismotility and visceral hypersensitivity at various clinical variants of irritable bowel syndrome
by: Ekaterina A. Bubnova, et al.
Published: (2018-08-01)

Evaluation of the functional gastrointestinal diseases concept from standpoints of Rome IV (2016) diagnostic criteria (review)
by: D. N. Andreyev, et al.
Published: (2018-08-01)

Возможности применения Опросника «7х7» (7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Postcholecystectomy syndrome: the modern approach: resolution of Advisory council
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Treatment compliance of patients with gastro-intestinal diseases
by: O. P. Alekseyeva, et al.
Published: (2016-08-01)

Short bowel syndrome: pathogenesis, clinical presentation and treatment
by: Anna F. Sheptulina, et al.
Published: (2016-08-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

The resolution of Advisory council «How to improve treatment results functional dyspepsia and irritable bowel syndrome»?
by: V. T. Ivashkin, et al.
Published: (2016-08-01)

Chronic inflammatory bowel diseases: the course and treatment methods in Russian Federation (Results of multicenter population-based one-stage observational study)
by: L. . Khalif, et al.
Published: (2018-08-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Noninvasive markers of inflammatory bowel disease activity
by: A. V. Nikitin, et al.
Published: (2018-08-01)

Diagnostics and treatment of biliary dyskinesia: clinical guidelines of the Russian gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Clinical guidelines for the diagnosis and treatment of patients with irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2014-08-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

Microbiome role in pancreatic diseases development
by: Yu. V. Evsyutina, et al.
Published: (2018-08-01)

Role of emotional disorders, personality features and disorders of intraceptive sensation in development of somatic symptoms at irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2013-12-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)